Medify Solutions Ltd.

Medify Solutions Limited (Pink Sheets - MDFY) - to Acquire Voice 2 Voice Limited

Stafford, England (ots/PRNewswire) - Medify Solutions Limited (Pink Sheets - MDFY) confirmed today that the Group has successfully concluded the negotiations to acquire, as a fully owned subsidiary, Voice 2 Voice Limited in the UK. Voice 2 Voice will continue to operate under its existing management and commercial terms including all current and prospective contracts. This acquisition delivers, mobile, fixed line, data and voice services into one new Group. In addition , the management team of Voice 2 Voice will bring a critical strengthening and depth into the executive team of Medify Solutions. What is Voice 2 Voice (www.voice2voice.co.uk)? A totally independent, leading UK fixed line and hosted IP telecommunication and integrated voice network company. Specializing in multi-site UK and European businesses in the commercial, governmental and Healthcare sectors. Combining telecommunications focus with a dynamic and flexible approach to meeting customers' business needs has helped us to build a reputation for dealing with PBX and networking requirements. Voice 2 Voice have established themselves as a Tier 2 Service Level Provider to AlwaysON to empower voice and data resellers to use converged voice and data communications efficiently and at a significantly lower cost. What does this mean to investors and Medify Solutions? The Medify Group now has a wholly owned suite of fixed line and mobile solutions to market directly to the general enterprise and Global Healthcare markets. The group benefits immediately with a product and go to market infrastructure, with both businesses gaining synergies and economies of scale. The immediate Voice 2 Voice revenue delivered as a subsidiary will be booked to the Group financial accounts of Medify Solutions Limited US. This consolidation strengthens both companies for the expansion of Voice 2 Voice and the MedifyRemote roll-out. This creates a suite of telecoms services, installation, support, fixed line, mobile, voice and data to the enterprise and Healthcare sectors; under a single Group entity. Market Capitulation & Revenues - Voice 2 Voice has invoiced and forecast income to the value of US$1.6m in their current financial year, at a gross profit margin in approximately 40%. Based on reoccurring revenue for Voice 2 Voice of US$5m over the next 24 months, the additional market Cap of the Medify Group, based on Voice 2 Voice alone, would typically be in the region of US$15m dollars. This would equate to a share price increase in the region of US$1.50 (post reverse stock split). This news release contains forward-looking statements that are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of such forward-looking statements. The words "estimate," "project," "intends," "expects," " believes," and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbour" provisions of the Private Securities Litigation Reform Act of 1995. For a more complete description of these and other risk factors that may affect the future performance of Medify Solutions Limited, see "Risk Factors" in the Company's Annual Report on Form 10-KSB and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made and the Company undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events. ots Originaltext: Medify Solutions Ltd. Im Internet recherchierbar: http://www.presseportal.ch Contact: For further information: Press Office email: press@medifysolutions.com; Enquires to: Chris Hill, +44-(0)-845-03-44-095

Das könnte Sie auch interessieren: